STOCK TITAN

Camp4 Therapeutics Corp. Stock Price, News & Analysis

CAMP Nasdaq

Welcome to our dedicated page for Camp4 Therapeutics news (Ticker: CAMP), a resource for investors and traders seeking the latest updates and insights on Camp4 Therapeutics stock.

CAMP4 Therapeutics Corporation (Nasdaq: CAMP) is a clinical-stage biopharmaceutical company developing regulatory RNA-targeting therapeutics designed to upregulate gene expression and restore healthy protein levels in genetic diseases. The CAMP news feed highlights how the company advances its antisense oligonucleotide (ASO) pipeline, progresses clinical and preclinical programs, and enters strategic collaborations.

Readers can follow CAMP4’s updates on its SYNGAP1-related disorders program, including announcements about GLP toxicology studies for CMP-SYNGAP-01, translational data in humanized mouse models and non-human primates, and plans for Phase 1/2 clinical trial applications. News items also cover the company’s Urea Cycle Disorders program and the CMP-CPS-001 (CMP-001) Phase 1 trial, where CAMP4 has reported safety and pharmacokinetics data from single and multiple ascending dose cohorts in healthy volunteers.

CAMP4’s news flow includes financial and corporate updates such as private placements, underwritten offerings of common stock, and use of proceeds to support development of its product candidates. The company also reports on strategic agreements, including a research, collaboration and license agreement with GSK to discover and develop ASO drug candidates for neurodegenerative and kidney disease indications using CAMP4’s RAP Platform.

In addition, CAMP4 issues press releases on scientific presentations at major meetings, corporate highlights, and inducement grants under Nasdaq Listing Rule 5635(c)(4). Investors and observers can use this news page to review CAMP4’s reported milestones, research progress, and financing activities related to its regulatory RNA-targeting therapeutic strategy.

Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced the launch of its Supply Chain Visibility solution through its subsidiary, Tracker Network, for pan-European logistics operators. This real-time cargo tracking system is crucial for high-value and high-risk shipments, particularly in industries like pharmaceuticals and food. The solution leverages wireless sensors to monitor shipment conditions and offers compliance documentation. It aims to enhance supply chain efficiency and reduce spoilage, addressing challenges highlighted during the pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.39%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.52%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP), a leader in connected intelligence, announced that CEO Jeff Gardner and CFO Kurt Binder will meet with investors at Oppenheimer’s 7th Annual Emerging Growth Conference on May 10, 2022. This virtual event aims to enhance operational performance through a data-driven solutions ecosystem. Portfolio managers and analysts interested in scheduling meetings should contact their Oppenheimer representative. CalAmp delivers solutions that monitor and recover essential assets across multiple sectors, boasting over one million software subscribers and ten million edge devices deployed worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.74%
Tags
conferences
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced that 272 Capital Master Fund Ltd. has nominated six candidates for election to its Board of Directors at the upcoming 2022 Annual Meeting. This comes amid the company’s ongoing transformation from a telematics-based business to a software and subscription services model. CalAmp reported a significant increase in Software and Subscription Services revenue, which rose 19% year-over-year in Q4 2022, now representing 60% of total revenues. The Board is reviewing the nominees while emphasizing its commitment to shareholder value creation and ongoing engagement with stockholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.12%
Tags
none
-
Rhea-AI Summary

CalAmp reported a 19% increase in Software and Subscription Services revenue year-over-year, reaching $41 million, representing 60% of total revenue. Remaining Performance Obligations rose 47% to $200 million

However, total revenue for the fourth quarter was $68.4 million, slightly down from the prior quarter, and annual revenue decreased from $308.6 million to $295.8 million. The company reported a GAAP net loss of $9.2 million for the quarter and $31.1 million for the year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.4%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
none
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced it will release its fiscal 2022 fourth quarter and full-year financial results on April 28, 2022, after market close. The company will host a conference call to discuss these results at 5:00 p.m. Eastern Time, accessible via webcast or by dialing in. CalAmp specializes in connected intelligence, helping businesses track and recover assets through real-time insights. The company supports various sectors including transportation, logistics, and automotive, boasting over one million subscribers and 20 million products deployed globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.09%
Tags
conferences earnings
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) has announced the promotion of Brett Jackson to senior vice president of transportation and logistics. In his new role, Jackson will lead the sales team and revenue generation strategies while reporting to interim Chief Revenue Officer Maurizio Iperti. Since joining CalAmp in 2021, Jackson has expanded partnerships and focused on SaaS solutions for fleet operators to enhance cost efficiency and productivity. The company aims to leverage its edge-to-cloud telematics platform for better asset management in the transportation sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.26%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) has partnered with Noregon to enhance remote vehicle diagnostics and predictive maintenance for fleet operators. This collaboration integrates CalAmp's iOn fleet management software with Noregon's TripVision, enabling proactive alerts for vehicle issues and optimized maintenance decisions. The predictive health scores will help reduce maintenance costs and prevent costly breakdowns, thereby improving fleet performance and operational efficiency. This partnership aims to ensure greater safety and productivity for fleet operators.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
partnership
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced a strengthened partnership with NG Bailey to enhance fleet safety and efficiency. Tracker Network (UK) Limited, a CalAmp subsidiary, will implement new dashcam technology across NG Bailey's 240 service vans. This initiative aims to reduce accidents and insurance costs while improving driver behavior, with previous telematics already achieving a 65% reduction in incidents. The collaboration aims to further decrease fuel usage and maintenance costs, showcasing the benefits of innovative fleet management solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.21%
Tags
none

FAQ

What is the current stock price of Camp4 Therapeutics (CAMP)?

The current stock price of Camp4 Therapeutics (CAMP) is $5.41 as of March 13, 2026.

What is the market cap of Camp4 Therapeutics (CAMP)?

The market cap of Camp4 Therapeutics (CAMP) is approximately 279.1M.

CAMP Rankings

CAMP Stock Data

279.12M
42.94M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE

CAMP RSS Feed